China Grand Pharmaceutical and Healthcare Holdings Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations, pharmaceutical intermediates, specialized pharmaceutical raw materials, and healthcare products. The company offers pharmaceutical preparations, such as cerebro-cardiovascular, ophthalmic gel and eye drops, antibacterial, antibiotics, and antipyretics and analgesic products; and active pharmaceutical ingredients (APIs), which include analgin, metronidazole and chloramphenicol, and other amino acids. It also provides steroid hormones APIs and its intermediates, including glucocorticoid and sex hormones, as well as prednisone series. In addition, the company offers Taurine, an organic amino acid that is used to enhance immunity system and increase level of cell differentiation, growth, and supplement in infant milk powder, as well as used in energy drinks and in treatment of various heart diseases. Further, it provides agricultural chemicals comprising bio-pesticides, biocides, and bio-feed additives; and fine chemicals, such as calcium superphosphate and dimethyl sulfate. China Grand Pharmaceutical and Healthcare Holdings Limited operates primarily in the People’s Republic of China, as well as in the United States, Europe, Asia, and internationally. The company was incorporated in 1995 and is based in Central, Hong Kong. China Grand Pharmaceutical and Healthcare Holdings Limited is a subsidiary of Outwit Investments Limited.
china grand pharmaceutical a
(512:Hong Kong Stock Exchange)
99 Queen’s Road
Sponsored Financial Commentaries
To contact CHINA GRAND PHARMACEUTICAL A, please visit www.chinagrandpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.